Pharma Seeking Democratic Allies In Senate: Nelson, Bayh May Be Contacts
Executive Summary
The retirement of Sen. John Breaux (D-La.) means that the brand name pharmaceutical industry is losing one of its best allies in the Senate minority heading into the Medicare Rx implementation process
You may also be interested in...
HHS Price Negotiators: Wyden, Thompson And “Non-Interference”
Incoming Senate Finance Committee member Ron Wyden (D-Ore.) is likely to play a central role in the push for legislation to give HHS greater leverage over drug pricing under Medicare
HHS Price Negotiators: Wyden, Thompson And “Non-Interference”
Incoming Senate Finance Committee member Ron Wyden (D-Ore.) is likely to play a central role in the push for legislation to give HHS greater leverage over drug pricing under Medicare
Medicare Rx Course Is Clearer Following Bush Victory
President Bush's victory in the Nov. 2 election means that the Centers for Medicare & Medicaid Services will have a chance to create a stand-alone drug insurance program under Medicare